Medgenics Announces Participation in Upcoming Conferences
May 07, 2015 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, May 7, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides in...
Medgenics Reports First Quarter 2015 Financial Results
April 17, 2015 08:00 ET
|
Medgenics, Inc.
Commenced enrollment in mid-dose arm of MDGN-201 study
Initiated peritoneal dialysis study in Israel
Filed U.S. IND for TARGTEPO renal anemia programs
Advanced collaboration...
Medgenics to Host Conference Call to Announce First Quarter 2015 Results on April 17, 2015
April 02, 2015 16:01 ET
|
Medgenics, Inc.
PHILADELPHIA, April 2, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Friday, April 17, 2015 at 8:30 a.m. ET to discuss first quarter 2015...
Medgenics to Present at Upcoming Investor Conferences
March 02, 2015 16:01 ET
|
Medgenics, Inc.
PHILADELPHIA, March 2, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
Medgenics Reports Fourth Quarter and Full Year 2014 Financial Results
February 13, 2015 08:00 ET
|
Medgenics, Inc.
Proof of concept established for TARGTTM platform
Enrollment initiated in mid-dose arm of MDGN-201 study; low-dose arm fully enrolled
Preclinical peptide programs...
Medgenics to Host Conference Call to Announce Fourth Quarter and Full Year 2014 Results on February 13, 2015
January 30, 2015 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, Jan. 30, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Friday, February 13, 2015 at 8:30 a.m. ET to discuss fourth quarter...
Medgenics to Present at Biotech Showcase 2015 Conference
January 08, 2015 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
Medgenics Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock
December 01, 2014 16:01 ET
|
Medgenics, Inc.
PHILADELPHIA, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
Medgenics to Present at 26th Annual Piper Jaffray Healthcare Conference
November 25, 2014 16:01 ET
|
Medgenics, Inc.
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
Medgenics Prices Public Offering of Common Stock
November 25, 2014 09:00 ET
|
Medgenics, Inc.
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the pricing of 5,125,000 shares of its common stock in a previously announced underwritten public...